search
Back to results

Promoting Weight Loss and Psychological Well-being in Obese Patients

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
cognitive-behavioral life style intervention
wellbeing intervention
treatment as usual
Sponsored by
University of Bologna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring obese patients, psychological well being, weight loss, depression, psychological distress, life-style intervention, demoralization

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • obese (BMI ≥ 30)
  • aged ≥18 years
  • willing to participate in the study.

Exclusion Criteria:

  • inability to provide informed consent to participate in the study (i.e. psychotic or mentally impaired patients);
  • insufficient knowledge of Italian;
  • presence of a medical condition associated with unintentional weight loss or gain;
  • presence of major psychiatric illness and cognitive deficit;
  • participation in another weight-loss program;
  • use of medication for weight loss;
  • history of weight loss surgery or weight loss surgery scheduled during the last year or within 16 months from the beginning of the study;
  • being pregnant or intended pregnancy during the last year or within 16 months from the beginning of the study.

Sites / Locations

  • SSD Malattie del Metabolismo e Dietetica Clinica Policlinico Sant'Orsola- Malpighi

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Cognitive Behavioral life-style and well-being intervention

Cognitive Behavioral life-style intervention

Arm Description

Participants will receive 12 group-based 2-hour weekly sessions for life-style modification and then 4 group-based 2-hour weekly sessions of the well-being intervention in addition to the treatment as usual.

Participants will receive 12 group-based 2-hour weekly sessions for life-style modification in addition to the treatment as usual.

Outcomes

Primary Outcome Measures

4-month Change in body weight in kg
4-month average change in body weight (kg) from baseline to 4 months. Weight will be measured with a standard balance beam scale with the participant in a lightweight clothing.
4-month Change in body weight in %
4-month average change in body weight as a percentage of start weight
10-month change in body weight in kg
10-month average change in body weight (kg) from baseline to 10 months.
10-month change in body weight in %
10-month average change in body weight as a percentage of start weight
16-month change in body weight in kg
16-month average change in body weight (kg)
16-month change in body weight in %
16-month average change in body weight as a percentage of start weight
Change in Body mass Index (BMI)
It will be computed as body weight (kg) divided by the square of height (m²).

Secondary Outcome Measures

Change in psychological well-being
It will be measured with the Psychological WellBeing scale, a 42-item self-rating scale, which includes six dimensions: self-acceptance, positive relations with others, autonomy, environmental mastery, purpose in life and personal growth. The respondents are asked to indicate on a 6-likert scale the extent to which they agree with each statement. Each dimension may range from 7-42, with higher scores indicating greater psychological well-being.
Change in the prevalence of depression
It will be measured by well-trained researcher with The Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - 5th edition (SCID-5-CV).
Change in the prevalence of demoralization
It will be measured by well-trained researchers with The Diagnostic Criteria for Psychosomatic Research-Revised Semi-Structured Interview- Revised (DCPR-R)
Change in psychological distress
It will be measured by the Symptom Questionnaire (SQ), a 92-item self-rating instrument with dichotomous responses divided into 4 dimensions: depression, anxiety, somatization and hostility/irritability. Each dimension consists in a symptom sub-scale including 17 questions and a well being one with 6 questions. Scores may range from 0 to 17 for each symptom sub-scale and from 0 to 6 for each well-being sub-scale. For each dimension, higher scores indicate more severe psychological distress.
Change in lifestyle
It will be measured with GOSPEL (GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction - GOSPEL study) questionnaire, a 32-item self-rating instrument for the assessment of physical activity levels, eating habits, and stress levels used among patients who need to change their lifestyle. The subscale on physical activity includes eight 4-point items with a total score ranging from 0 (poor/absent physical activity) to 20 (very high physical activity). The subscale on eating habits consists of ten 4-point items regarding Mediterranean diet based on the frequency of healthy food consumption, with a total score ranging from 0 (worst) to 30 (best). Three additional 4-point items on eating behavior are also included: their total score may range from 0 (bad dietary behavior) to 9 (healthy dietary behavior). The subscale on stress management includes seven 4-point items which total score may range from 0 (inadequate) to 21 (optimal).

Full Information

First Posted
May 16, 2019
Last Updated
June 27, 2021
Sponsor
University of Bologna
Collaborators
IRCCS Azienda Ospedaliero-Universitaria di Bologna
search

1. Study Identification

Unique Protocol Identification Number
NCT03962205
Brief Title
Promoting Weight Loss and Psychological Well-being in Obese Patients
Official Title
Promoting Weight Loss and Psychological Well-being in Obese Patients: Combination of Behavioral Life Style and Well-Being Intervention
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
September 10, 2018 (Actual)
Primary Completion Date
March 15, 2021 (Actual)
Study Completion Date
March 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Bologna
Collaborators
IRCCS Azienda Ospedaliero-Universitaria di Bologna

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The goal of the proposed research is to assess the effects of a sequential combination of lifestyle and well-being intervention on weight loss and psychological well-being. It is hypothesized that psychological well-being promotion as an adjunct to life-style intervention will outperform life style intervention alone in promoting weight loss and psychological well-being in obese individuals.
Detailed Description
The present study is a longitudinal, single blind, randomized controlled pilot trial. The participants will be recruited at the Center of Metabolism Diseases and Clinical Dietetics of Sant'Orsola Hospital in Bologna, directed by Prof. Giulio Marchesini Reggiani, after approval of the Ethics Committee of Azienda Ospedaliero-Universitaria of Bologna. Patients attending the Center of Metabolism Diseases and Clinical Dietetics during the enrollment period will be screened for inclusion and exclusion criteria by care coordinators or clinicians. Eligible patients will be required to sign the informed consent form and the consent form for personal data processing. The researchers will be in charge of explaining the project to make sure that it is fully understood by the patients. During the first 3 months, all the participants will undergo a behavioral program focusing on lifestyle modification. The participants who accomplish the program for life-style modification will be randomly assigned to either the control group or the experimental group. Generalized block randomization will be carried out by a computer program (the Random Allocation Software 2.0), with an allocation ratio of 1:1. Participants in the experimental group will receive a four-session intervention on psychological well-being. Each session will last one hour and will be offered weekly, based on the principles of Well-Being Therapy. Patients in the control group will only receive a treatment as usual (TAU), according to the instructions given by their clinicians. Data will be collected for each participant through questionnaires and interviews at baseline, at the end of the life-style intervention, at the end of the well-being intervention, and at 6 months of follow-up after the intervention. Given the nature of this study, it will not be possible for participants and treatment delivers to be blinded. Trained researchers, masked to the experimental allocation of patients, will perform measurements and analyses of the data to minimize potential bias.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obese patients, psychological well being, weight loss, depression, psychological distress, life-style intervention, demoralization

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
83 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cognitive Behavioral life-style and well-being intervention
Arm Type
Experimental
Arm Description
Participants will receive 12 group-based 2-hour weekly sessions for life-style modification and then 4 group-based 2-hour weekly sessions of the well-being intervention in addition to the treatment as usual.
Arm Title
Cognitive Behavioral life-style intervention
Arm Type
Placebo Comparator
Arm Description
Participants will receive 12 group-based 2-hour weekly sessions for life-style modification in addition to the treatment as usual.
Intervention Type
Behavioral
Intervention Name(s)
cognitive-behavioral life style intervention
Intervention Description
Cognitive Behavioral life-style modification: The intervention will be composed of 12 weekly sessions. Each session will last about two hours and will be administered in a group setting (maximum 20 participants). During the first two sessions, a clinician will introduce the program to the participants and motivate them to make life-style changes.In the next eight sessions a dietician will provide participants with basics of nutrition and will coach them to use a structured diary to monitor their eating behavior and physical activity. Next, a physician will introduce to the patients various weight loss surgeries in terms of the adverse events, indications and effects of each option.The last session will be held by a psychologist and will focus on providing participants with useful strategies to promote healthy eating habits and physical activity, including problem solving and goal setting.
Intervention Type
Behavioral
Intervention Name(s)
wellbeing intervention
Intervention Description
This program will consist of 4 weekly group-based sessions and each meeting will last about two hours. During the sessions, participants will be coached how to self-monitor their well-being episodes in everyday life, especially those associated with life-style change, by means of a structured diary. Patients will be then ecounraged to discuss their well-being experiences during group sessions, focusing on dysfunctional thoughts/beliefs interrupting them, fostering the identification of more functional thoughts. The psychologist will also teach them how to promote well-being situations through behavioral exercises and will introduce to the participants relevant psychological well-being dimensions (based on Carol Ryff's multidimensional model) associated with patients' experiences emerged during the treatment.
Intervention Type
Other
Intervention Name(s)
treatment as usual
Intervention Description
The treatment as usual will involve any recommendation given to the participants by their physicians, including diet, physical activity and medication.
Primary Outcome Measure Information:
Title
4-month Change in body weight in kg
Description
4-month average change in body weight (kg) from baseline to 4 months. Weight will be measured with a standard balance beam scale with the participant in a lightweight clothing.
Time Frame
Baseline, 4 months
Title
4-month Change in body weight in %
Description
4-month average change in body weight as a percentage of start weight
Time Frame
Baseline, 4 months
Title
10-month change in body weight in kg
Description
10-month average change in body weight (kg) from baseline to 10 months.
Time Frame
Baseline, 10 months
Title
10-month change in body weight in %
Description
10-month average change in body weight as a percentage of start weight
Time Frame
Baseline, 10 months
Title
16-month change in body weight in kg
Description
16-month average change in body weight (kg)
Time Frame
Baseline, 16 months
Title
16-month change in body weight in %
Description
16-month average change in body weight as a percentage of start weight
Time Frame
Baseline, 16 months
Title
Change in Body mass Index (BMI)
Description
It will be computed as body weight (kg) divided by the square of height (m²).
Time Frame
Baseline, 4 months,10 months,16 months
Secondary Outcome Measure Information:
Title
Change in psychological well-being
Description
It will be measured with the Psychological WellBeing scale, a 42-item self-rating scale, which includes six dimensions: self-acceptance, positive relations with others, autonomy, environmental mastery, purpose in life and personal growth. The respondents are asked to indicate on a 6-likert scale the extent to which they agree with each statement. Each dimension may range from 7-42, with higher scores indicating greater psychological well-being.
Time Frame
Baseline, 4 months,10 months,16 months
Title
Change in the prevalence of depression
Description
It will be measured by well-trained researcher with The Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - 5th edition (SCID-5-CV).
Time Frame
Baseline, 4 months,10 months,16 months
Title
Change in the prevalence of demoralization
Description
It will be measured by well-trained researchers with The Diagnostic Criteria for Psychosomatic Research-Revised Semi-Structured Interview- Revised (DCPR-R)
Time Frame
Baseline, 4 months,10 months,16 months
Title
Change in psychological distress
Description
It will be measured by the Symptom Questionnaire (SQ), a 92-item self-rating instrument with dichotomous responses divided into 4 dimensions: depression, anxiety, somatization and hostility/irritability. Each dimension consists in a symptom sub-scale including 17 questions and a well being one with 6 questions. Scores may range from 0 to 17 for each symptom sub-scale and from 0 to 6 for each well-being sub-scale. For each dimension, higher scores indicate more severe psychological distress.
Time Frame
Baseline, 4 months,10 months,16 months
Title
Change in lifestyle
Description
It will be measured with GOSPEL (GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction - GOSPEL study) questionnaire, a 32-item self-rating instrument for the assessment of physical activity levels, eating habits, and stress levels used among patients who need to change their lifestyle. The subscale on physical activity includes eight 4-point items with a total score ranging from 0 (poor/absent physical activity) to 20 (very high physical activity). The subscale on eating habits consists of ten 4-point items regarding Mediterranean diet based on the frequency of healthy food consumption, with a total score ranging from 0 (worst) to 30 (best). Three additional 4-point items on eating behavior are also included: their total score may range from 0 (bad dietary behavior) to 9 (healthy dietary behavior). The subscale on stress management includes seven 4-point items which total score may range from 0 (inadequate) to 21 (optimal).
Time Frame
Baseline, 4 months,10 months,16 months
Other Pre-specified Outcome Measures:
Title
Change in psychosocial profile
Description
It will be measured with the PsychoSocial Index (PSI). PSI is a 55-item self-rating scale, divided into 5 domains: 1) Sociodemographic and clinical data (12 questions on medical and demographic information); 2) Stress subscale (17 yes/no questions) with a score ranging from 0 to 17 (a higher score indicates greater stress); 3) Well-being subscale (6 yes/no questions) with a score ranging from 0 to 6 (a higher score indicates greater psychological well-being); 4) Psychological distress (15 four-point questions ranging from 0 to 3) with a total score from 0 to 45 (a higher score indicates greater psychological distress); 5) Abnormal Illness Behavior (3 four-point questions from 0 to 3) with a total score ranging from 0 to 9 (a higher score indicates more severe abnormal illness behavior). Finally, PSI includes one 4-point question on self-perceived quality of life, with a score from 0 to 4 (a higher score indicates better quality of life).
Time Frame
Baseline, 4 months,10 months,16 months
Title
Change in motivation for weight change
Description
It will be measured by the Goal Related Weight Questionnaire (GRWQ), which asks the respondents to self-report their dream, happy, acceptable, and disappointed weight in kilograms in the first part (4 items) and to indicate to which extent they expect weight loss to impact various aspects of their psycho-social and health-related functioning, with each item scored from 1 (extremely negative) to 10 (extremely positive), in the second part (21 items).
Time Frame
Baseline, 4 months,10 months,16 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: obese (BMI ≥ 30) aged ≥18 years willing to participate in the study. Exclusion Criteria: inability to provide informed consent to participate in the study (i.e. psychotic or mentally impaired patients); insufficient knowledge of Italian; presence of a medical condition associated with unintentional weight loss or gain; presence of major psychiatric illness and cognitive deficit; participation in another weight-loss program; use of medication for weight loss; history of weight loss surgery or weight loss surgery scheduled during the last year or within 16 months from the beginning of the study; being pregnant or intended pregnancy during the last year or within 16 months from the beginning of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chiara Rafanelli, MD,PhD
Organizational Affiliation
University of Bologna
Official's Role
Study Director
Facility Information:
Facility Name
SSD Malattie del Metabolismo e Dietetica Clinica Policlinico Sant'Orsola- Malpighi
City
Bologna
State/Province
Emilia Romagna
ZIP/Postal Code
40138
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
27043240
Citation
Fava GA. Well-Being Therapy: Current Indications and Emerging Perspectives. Psychother Psychosom. 2016;85(3):136-45. doi: 10.1159/000444114. Epub 2016 Apr 5. No abstract available.
Results Reference
background

Learn more about this trial

Promoting Weight Loss and Psychological Well-being in Obese Patients

We'll reach out to this number within 24 hrs